Key result
Human ES cell-derived vascular cells improve blood flow and accelerate neurological recovery after stroke in mice.
Answers are grounded in this paper and cite their sources.
Shows that transplanting human embryonic stem cell-derived vascular cells promotes vascular repair and reduces infarct volume after stroke in mice, indicating therapeutic potential.
BACKGROUND: We previously demonstrated that vascular endothelial growth factor receptor type 2 (VEGF-R2)-positive cells induced from mouse embryonic stem (ES) cells can differentiate into both endothelial cells (ECs) and mural cells (MCs) and these vascular cells construct blood vessel structures in vitro. Recently, we have also established a method for the large-scale expansion of ECs and MCs derived from human ES cells. We examined the potential of vascular cells derived from human ES cells to contribute to vascular regeneration and to provide therapeutic benefit for the ischemic brain. METHODS: Phosphate buffered saline, human peripheral blood mononuclear cells (hMNCs), ECs-, MCs-, or the mixture of ECs and MCs derived from human ES cells were intra-arterially transplanted into mice after transient middle cerebral artery occlusion (MCAo). RESULTS: Transplanted ECs were successfully incorporated into host capillaries and MCs were distributed in the areas surrounding endothelial tubes. The cerebral blood flow and the vascular density in the ischemic striatum on day 28 after MCAo had significantly improved in ECs-, MCs- and ECs+MCs-transplanted mice compared to that of mice injected with saline or transplanted with hMNCs. Moreover, compared to saline-injected or hMNC-transplanted mice, significant reduction of the infarct volume and of apoptosis as well as acceleration of neurological recovery were observed on day 28 after MCAo in the cell mixture-transplanted mice. CONCLUSION: Transplantation of ECs and MCs derived from undifferentiated human ES cells have a potential to contribute to therapeutic vascular regeneration and consequently reduction of infarct area after stroke.
No takes yet. Share an insight, caveat, or question.
Oyamada et al. (2008) studied Ischemic stroke (transient middle cerebral artery occlusion in mice). Intra-arterial transplantation of endothelial cells (ECs), mural cells (MCs), or a mixture of ECs and MCs derived from human embryonic stem cells vs. Phosphate buffered saline (saline) or human peripheral blood mononuclear cells (hMNCs) was evaluated on Cerebral blood flow, vascular density in the ischemic striatum, infarct volume, apoptosis, and neurological recovery on day 28. Transplanting human ES cell-derived ECs and MCs improved cerebral blood flow, reduced infarct volume, and accelerated neurological recovery on day 28 after MCAo in mice compared to saline or hMNCs.
Synapse has enriched 10 related papers. Consider them for comparative context: